david-cristina
Ageing, Biotech, Health & Longevity
  • Address :
  • Phone :
  • Mobile :
  • Fax :
  • Web :

David Cristina

David Cristina is SingularityU Portugal Expert in Ageing, Biotech, Health & Longevity. David received his PhD in Genetics of Ageing from UCSF, training under Cynthia Kenyon, one of the founders of the Ageing Research field and, despite his financial expertise, is a scientist at heart.

David Cristina is currently Executive Director at Fosun International, running Fosun’s European Healthcare Investment Team. His core expertise is in Biotech and Pharma.

He is experienced in Venture Capital, early-stage investment and venture-building and, since joining his latest position, has spent over two years working on public market investments and Private Equity.

David speaks frequently in public about science, investment and comedy.

Main Keynote Topic: Longevity Extension and Aging: 60 is the new 30, The Biology of Longevity

Finally, you can request David Cristina as a keynote speaker by filling out the form below or send us an email to: events@suportugal.org

Know more about our Faculty

Request a Speaker


    KeynoteWorkshopOtherSign me for SingularityU Portugal updates

    SingularityU team is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
    I agree to receive other communications from SingularityU Team.

    In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
    I agree to allow SingularityU Portugal team to store and process my personal data.

    You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.